Skip to main content

Table 1 Demographic features, paraoxonase activity and biochemical parameters in controls and lung cancer patient groups

From: Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

  Control group (n = 39) Patient group (n = 39) P value
Age (year) 64.0 ± 8.6 64.4 ± 8.9 0.861
Cigarette smoking (%) 64.1 89.7 0.014
Total cholesterol (mg/dl) 193.2 ± 48.5 165.1 ± 50 0.014
LDL cholesterol (mg/dl) 128.8 ± 35.3 116 ± 42.4 0.152
HDL cholesterol (mg/dl) 41.7 ± 10.9 34.9 ± 20.8 0.074
VLDL cholesterol (mg/dl) 32 ± 16.3 29.3 ± 11.5 0.393
Triglyceride (mg/dl) 160.8 ± 81.7 141.3 ± 53.9 0.219
PON1 (U/mL) 395.8 ± 116.6 252.7 ± 104.4 0.001
ARE (U/L) 167.7 ± 45 137.4 ± 57.6 0.018
PON1/ARE 2.4 ± 0.6 2.0 ± 0.9 0.008
PON/HDL 9.8 ± 2.9 8.1 ± 2.9 0.009
  1. Values are mean ± S.D. PON1: paraoxonase, ARE: arylesterase